Dr. Amy Seinfeld, D.O.
Board-Certified Osteopathic Physician · Family Medicine Board-Certified
28 years in clinical practice with expertise in primary care, including diabetes, weight management, hormone therapy, and peptides
Dr. Amy Seinfeld, D.O. is a physician board-certified by the American Osteopathic Board of Family Practice (current and up-to-date), with 28 years of clinical practice spanning primary care, diabetes management, weight management, hormone therapy, peptide therapy, and aesthetic medicine. She is the medical authority behind DrSeinfeld.com, where she formulates and reviews every product offered.
Dr. Seinfeld trained at Nova Southeastern University College of Osteopathic Medicine and completed her residency at North Shore University Hospital at Glen Cove, New York. Her clinical career spans urgent care, primary care, emergency medicine, and HIV medicine across multiple states — including managing a 26-bed Critical Access Hospital as Director of Trauma and Emergency Services in rural Northeastern Colorado. She maintains active medical licenses in California, Colorado, and Florida, along with an active DEA license.
Beyond clinical practice, Dr. Seinfeld has served as a Principal Investigator on multiple clinical research studies — including statewide diabetes-related Continuous Glucose Monitor implementation in Colorado, dermatology and migraine trials at PRECISION Clinical Research, and CCR5 inhibitor research for HIV. She has consulted with Novartis Pharmaceuticals on advisory boards and was an Official Speaker for GlaxoSmithKline (Epivir) and Abbott Laboratories (AndroGel).
In academic medicine, Dr. Seinfeld served as Family Medicine Clerkship Director at Nova Southeastern University College of Allopathic Medicine and held Clinical Assistant Professor appointments at both NSU's osteopathic (NSUCOM) and allopathic (NSUCMD) medical schools, where she taught and mentored medical students in clinical rotations.
At Ginspire Health, Dr. Seinfeld brings this combined clinical, research, academic, and pharmaceutical industry experience to every formulation decision. She personally developed GLOVERA, a unique line of skincare products, and oversees the formulation review process for the full DrSeinfeld.com product portfolio — from doctor-formulated intranasal peptide sprays to topical therapies and foundational supplements.
Dr. Seinfeld is a member of the American Osteopathic Association, holds Civil Surgeon Designation, and speaks Spanish and Hebrew. She has a particular interest in providing accessible, evidence-aligned wellness care to patients seeking preventive and longevity-focused solutions.
Areas of Clinical Expertise
Licensure & Credentials
- Board Certification: American Osteopathic Board of Family Practice (current & up-to-date)
- State Medical Licenses: California, Colorado, Florida
- DEA License: Active
- Designation: Civil Surgeon
- Hormone Therapy Certification: BHRT Academy (Donna White, 2020)
- Professional Membership: American Osteopathic Association
- Languages: English, Spanish, Hebrew
- Professional Profile: LinkedIn →
Education
- Doctor of Osteopathy (D.O.) — Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale, FL 1994 – 1998
- Post-Baccalaureate Pre-Medical Studies — University of Miami, Coral Gables, FL 1992 – 1993
- Bachelor of Fine Arts — University of Michigan, Ann Arbor, MI 1986 – 1990
Internship & Residency Training
- Residency — North Shore University Hospital at Glen Cove, Glen Cove, NY 1999 – 2001
- Internship — St. John's Episcopal Hospital, Far Rockaway, NY 1999
- Internship — St. Luke's Presbyterian Hospital, Denver, CO 1998
Advanced Specialty Training
- BHRT Training Academy with Donna White 2020
- BHRT Shadowing with Dr. Erika Schwartz, NYC 2012
- Certified Aesthetic Injector, Aesthetic Medical Educators 2009
- AETC Degree: AIDS Education Training & Preceptorship, University of Miami, Infectious Disease Department 2005
Selected Clinical Experience
-
Telehealth Physician & Formulator — Ginspire Health LLC (DrSeinfeld.com) Current
Preventive medicine, BHRT, peptides, and the GLOVERA skincare line -
Director of Trauma & Emergency Services — Haxtun Health, Rural Northeastern Colorado 2021 – 2025
Managed a 26-bed Critical Access Hospital; clinic, hospital, ER, inpatient, and nursing-home settings; oversaw quality measures and outpatient procedures -
Primary Care Physician — Associates MD, Plantation, FL 2014 – 2021
Women's health, diabetes management, nutrition and weight loss, aesthetics -
Founder & Solo Practitioner — Amy Seinfeld, DO PA, North Miami Beach, FL 2008 – 2012
Primary care, HTN/diabetes management, aesthetics, injectables (Botox, filler, laser) -
Primary Care & HIV Medicine — Underserved Urban Community of South Florida, Miami Beach 2004 – 2006
Primary care and HIV medicine for medically underserved populations
Clinical Research
- 4CGM Diabetes Research — Official Site. Statewide Colorado study on Continuous Glucose Monitor implementation in diabetic care plans. 2022 – 2024
- Multiple clinical trials at PRECISION Clinical Research — Primary Investigator and Sub-Investigator. Studies spanning dermatology, bladder incontinence, and migraine headaches. 2019 – 2020
- CCR5 Inhibitors Investigation — Primary Investigator. Official study site for new HIV medication at Miami Beach, FL. 2005 – 2006
- HRT in Women: Risks and Benefits — Residency Research Project. North Shore Hospital, Glen Cove, NY. 2001
Pharmaceutical Industry Consultancy & Speaking
- Novartis Pharmaceuticals — Consultant & Advisory Board Member, Innovation of new pharmaceutical agents 2020 – 2021
- Abbott Laboratories — Official Speaker, AndroGel (Testosterone Gel) 2005 – 2006
- GlaxoSmithKline — Official Speaker, Epivir (Lamivudine) 2005 – 2006
Academic & Teaching Appointments
- Family Medicine Clerkship Director — Nova Southeastern University College of Allopathic Medicine 2020
- Clinical Assistant Professor — Nova Southeastern University College of Osteopathic Medicine (NSUCOM) 2014 – 2021
- Clinical Assistant Professor — Nova Southeastern University College of Allopathic Medicine (NSUCMD) 2018 – 2021
